Activating GPR139 in rats reduced excessive alcohol use and pain of withdrawal
Activation of a receptor with no known function in the brain reduces excessive alcohol use and the pain of withdrawal, according to preclinical research in male rats. The study, published in eNeuro, suggests a new approach towards the treatment of alcohol use disorder.
More than a third of approved pharmaceutical drugs target G protein-coupled receptors (GPCRs). One receptor belonging to this family, GPR139, is highly expressed in the habenula — a brain region with a critical role in addiction.
Olivier George and colleagues used a rat model of alcohol dependence and a substance that activates GPR139 to establish a previously unknown role for the receptor in addiction-like behavior. The researchers found that activation of GPR139 reduced alcohol intake and restored pain sensitivity thresholds only in alcohol-dependent mice that showed compulsive-like alcohol consumption akin to problematic drinking in humans. This study is the first to establish an effect of GPR139 manipulation on behavior and encourages investigation of the receptor as a potential drug target in the development of medications for alcohol dependence.
Learn more: New target for treating alcoholism
The Latest on: Alcohol use disorder
via Google News
The Latest on: Alcohol use disorder
- FDA clears Raleigh company’s female libido pill for use with alcoholon September 6, 2019 at 4:00 am
Previously, the FDA required Sprout to include a warning on its drug, Addyi, which treats hypoactive sexual desire disorder, noting that alcohol use with the pill causes an increased risk of fainting.
- CA Hosting Rally For Alcohol And Recovery Monthon September 5, 2019 at 3:44 pm
"It is critical that people experiencing substance use disorders receive the support they need," said Sacramento County Alcohol and Drug Services Division Manager, Lori Miller. "The reality is ...
- Marijuana use seven times higher among bisexual women finds studyon September 5, 2019 at 3:32 pm
... and marijuana use and marijuana use disorder among a nationally representative sample of adults in the United States, 2015-2017: Sexual identity and gender matter,” was published in the journal ...
- FDA Removes Alcohol Ban with Addyi - the First-and-Only Non-Hormonal Treatment for Hypoactive (Low) Sexual Desire Disorder (HSDD)on September 4, 2019 at 9:32 pm
Women seeking treatment for the most common form of female sexual dysfunction, Hypoactive (low) Sexual Desire Disorder (HSDD ... or ban, on alcohol use with Addyi ® (flibanserin), the first ...
- Medical marijuana laws impact use among sexual minorities differently than heterosexualson September 4, 2019 at 8:45 am
The findings are online in the journal Drug and Alcohol Dependence ... any past-year medical marijuana use, daily/near-daily marijuana use, and marijuana use disorder. They also tested the ...
- Fun Sober Activities to Prevent Alcohol Relapseon September 3, 2019 at 3:39 pm
Learn about alcohol use disorder, along with five ideas for fun sober activities you can do to help maintain sobriety. Alcohol use disorder is also often referred to as alcoholism. It can be difficult ...
- ‘Ongoing vigilance’ needed raising children with fetal alcohol spectrum disorderon September 2, 2019 at 1:46 pm
Moreland adopted the siblings when they were just toddlers, and she was prepared for learning disabilities because of their birth mother's troubled history including substance use and homelessness.
- Allele-specific expression and high-throughput reporter assay reveal functional genetic variants associated with alcohol use disorderson September 2, 2019 at 9:34 am
Genome-wide association studies (GWAS) of complex traits, such as alcohol use disorders (AUD), usually identify variants in non-coding regions and cannot by themselves distinguish whether the ...
- Adial in home stretch of anti-alcohol abuse drug trialson September 1, 2019 at 12:00 pm
... reduce alcohol cravings as a way to effectively curb alcohol intake in people who have a genetic predisposition to alcohol use disorder. The newest trials will take place in Europe because, ...
via Bing News